Bexion Pharmaceuticals, Inc. Announces First Patient Dosed with BXQ-350 in the RETRO Clinical Study
/PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biologics for the treatment of cancer and neuropathy,...
United States Margaret Van Gilse Scott Shively Prnewswire Bexion Pharmaceuticals Inc Bexion Pharmaceuticals Bexion Pharmaceuticals Inc
Source: prnewswire.com